XML 22 R10.htm IDEA: XBRL DOCUMENT v3.25.2
Restructuring and Impairment Charges
8 Months Ended
Sep. 06, 2025
Restructuring and Related Activities [Abstract]  
Restructuring and Impairment Charges Restructuring and Impairment Charges
2019 Multi-Year Productivity Plan (2019 Productivity Plan)
The 2019 Productivity Plan leverages new technology and business models to further simplify, harmonize and automate processes; re-engineers our go-to-market and information systems, including deploying the right automation for each market; and simplifies our organization and optimizes our manufacturing and supply chain footprint. To build on the successful implementation of the 2019 Productivity Plan, in 2024, we further expanded and extended the plan through the end of 2030 to take advantage of additional opportunities within the initiatives described above. As a result, we expect to incur pre-tax charges of approximately $6.15 billion, including cash expenditures of approximately $5.1 billion. These pre-tax charges are expected to consist of approximately 50% of severance and other employee-related costs, 10% for asset impairments (all non-cash) resulting from plant closures and related actions, and 40% for other costs associated with the implementation of our initiatives.
The total plan pre-tax charges are expected to be incurred by segment approximately as follows:
PFNAPBNAIB FranchiseEMEALatAm FoodsAsia Pacific FoodsCorporate
Expected pre-tax charges20 %25 %%25 %10 %%15 %
A summary of our 2019 Productivity Plan charges is as follows:
12 Weeks Ended36 Weeks Ended
9/6/20259/7/20249/6/20259/7/2024
Cost of sales$16 $10 $119 $16 
Selling, general and administrative expenses 126 214 435 363 
Impairment of intangible assets— 14 — 14 
Other pension and retiree medical benefits (income)/expense (a)
(1)13 22 
Total restructuring and impairment charges$141 $245 $567 $415 
After-tax amount$116 $195 $467 $325 
Impact on net income attributable to PepsiCo per common share$(0.08)$(0.14)$(0.34)$(0.24)
12 Weeks Ended36 Weeks EndedPlan-to-Date
9/6/20259/7/20249/6/20259/7/2024
through 9/6/2025
PFNA$32 $$147 $47 $579 
PBNA19 128 192 143 697 
IB Franchise2 15 7 15 58 
EMEA69 35 118 75 879 
LatAm Foods17 11 36 32 283 
Asia Pacific Foods5 9 96 
Corporate (a)
(2)39 45 75 463 
142 238 554 393 3,055 
Other pension and retiree medical benefits (income)/expense (a)
(1)13 22 139 
Total$141 $245 $567 $415 $3,194 
(a)Income amount represents adjustments for changes in estimates of previously recorded amounts.
12 Weeks Ended36 Weeks EndedPlan-to-Date
9/6/20259/7/20249/6/20259/7/2024
through 9/6/2025
Severance and other employee costs$46 $151 $168 $233 $1,602 
Asset impairments22 30 109 34 415 
Other costs73 64 290 148 1,177 
Total$141 $245 $567 $415 $3,194 
Severance and other employee costs primarily include severance and other termination benefits, as well as voluntary separation arrangements. Other costs primarily include costs associated with the implementation of our initiatives, including contract termination costs, consulting and other professional fees.
A summary of our 2019 Productivity Plan activity for the 36 weeks ended September 6, 2025 is as follows:
Severance and Other Employee CostsAsset
Impairments
Other CostsTotal
Liability as of December 28, 2024$338 $— $26 $364 
2025 restructuring charges
168 109 290 567 
Cash payments (a)
(245)— (309)(554)
Non-cash charges and translation(1)(109)(1)(111)
Liability as of September 6, 2025$260 $ $6 $266 
(a)Excludes cash expenditures of $8 million reported in the cash flow statement in pension and retiree medical contributions.
The majority of the restructuring accrual at September 6, 2025 is expected to be paid within a year.
Other Productivity Initiatives
There were no material charges related to other productivity and efficiency initiatives outside the scope of the 2019 Productivity Plan.
We regularly evaluate different productivity initiatives beyond the productivity plan and other initiatives described above.
For information on additional impairment charges, see Notes 1 and 4 for impairment and other charges taken primarily related to the impairments of the Rockstar and Be & Cheery brands.